PRECIGEN, INC. — Director's Dealing 2020

Jan 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2020-01-02

Reporting Person: Reed Thomas D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-02	Common Stock	M	9766	—	Acquired	138350	Direct
2020-01-03	Common Stock	S	2986	$5.7699	Disposed	135364	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Restricted Stock Units	$	M	9766	Disposed		Common Stock (9766)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	62840	Indirect
Common Stock	41705	Indirect
Common Stock	2440	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of XON common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.

F3: Held by the Thomas David Reed Living Trust dated February 4, 2011.

F4: Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.

F5: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in two equal annual installments on each of January 2, 2021 and 2022.